packageThiotepa

thiotepa

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Thiotepa is an alkylating anticancer drug used to treat cancers such as lymphoma and bladder cancer, and as part of conditioning before stem cell transplantation. It remains in use and is authorised in the European Union, mainly in hospital settings for oncology and transplant conditioning.

Summary written by glm-5.3-flash from Wikidata Q416507 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:thiotepa
ATC codes:L01AC01
DrugBank:DB04572
PubChem CID:5453
ChEBI:9570
Wikidata:Q416507
formula:C6H12N3PS
molar mass:189.217 g/mol (PubChem CID 5453)
logP:0.5 (Drugs.Common 25.09, not verified)

Metabolites

Hydroxycyclophosphamide44-hydroxycyclophosphamidemolar mass unknown
TEPATEPA173.156 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
Hydroxycyclophosphamide4metabolite: 4-hydroxycyclophosphamide
TEPAmetabolite: TEPA